---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-021383"
form_type: "8-K"
ticker: "ARE"
cik: "0001035443"
company_name: "ALEXANDRIA REAL ESTATE EQUITIES, INC."
filed_at: "2025-03-06T23:59:59+00:00"
generated_at: "2026-05-25T04:47:16.001949+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Alexandria RE elects Claire Aldridge, PhD to board, effective March 14, 2025

## Summary
- Board size increased from 8 to 9; Aldridge serves until 2025 annual meeting.
- She was chief strategy officer at Form Bio, a Colossal Biosciences spinout, with 25+ years in life science.
- Upon election, receives 1,000 restricted shares vesting on second anniversary.
- Appointed to Life Science Committee; determined independent under NYSE and SEC rules.

## SEC filing metadata
- accession: 0001104659-25-021383
- form_type: 8-K
- ticker: ARE
- cik: 0001035443
- company_name: ALEXANDRIA REAL ESTATE EQUITIES, INC.
- filed_at: 2025-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035443/000110465925021383/0001104659-25-021383-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035443/000110465925021383/tm258282d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-021383
- JSON: https://secwatch.observer/filing/0001104659-25-021383.json
- Plain text: https://secwatch.observer/filing/0001104659-25-021383.txt

## Key facts
- Executive change
  Claire Aldridge, Ph.D. was elected as director at ALEXANDRIA REAL ESTATE EQUITIES, INC..
  - Action: elected
  - Role: director
  source text: elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1035443/000110465925021383/0001104659-25-021383-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.